Skip to main content

Donald C. Moore, PharmD, BCPS, BCOP, DPLA, FCCP, FASHP

Authored Items
Hypertension Caused by VEGF-Signaling Pathway Inhibitors
Donald C. Moore, PharmD, BCPS, BCOP, DPLA, FCCP, FASHP, Margaret M. Kientzel, PharmD, Adenike Fasan, BPharm
JHOP - December 2017 Vol 7, No 4 in Symptom Management Overview, VEGF Inhibitors
EGFR Inhibitor–Associated Papulopustular Rash
Donald C. Moore, PharmD, BCPS, BCOP, DPLA, FCCP, FASHP
JHOP - March 2017 Vol 7, No 1 in Supportive Care
Last modified: March 21, 2025
The development and publication of these materials has been supported by Takeda Oncology. The views and opinions expressed are from the authors and not necessarily those of Takeda Oncology.
(JOB-CODE-HERE)